Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 259, doi. 10.1002/jcph.2158
- By:
- Publication type:
- Article
Works matching IS 00912700 AND DT 2023 AND VI 63 AND IP 2
Results: 12
1
2
Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open-Label, Single-Dose, Parallel Group Study.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 250, doi. 10.1002/jcph.2155
- By:
- Publication type:
- Article
3
A Drug-Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 239, doi. 10.1002/jcph.2159
- By:
- Publication type:
- Article
4
Evaluation of the Pharmacokinetic Drug Interaction of Capmatinib With Itraconazole and Rifampicin and Potential Impact on Renal Transporters in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 228, doi. 10.1002/jcph.2153
- By:
- Publication type:
- Article
5
P-Glycoprotein and Organic Anion Transporter Polypeptide 1B/Breast Cancer Resistance Protein Drug Transporter Activity in Pregnant Women Living With HIV.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 219, doi. 10.1002/jcph.2152
- By:
- Publication type:
- Article
6
Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors: A Meta-Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 210, doi. 10.1002/jcph.2150
- By:
- Publication type:
- Article
7
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 197, doi. 10.1002/jcph.2164
- By:
- Publication type:
- Article
8
Evaluation of Hemoglobin Response to Treatment With Enarodustat Using Pharmacometric Approach in Japanese Anemic Patients With Chronic Kidney Disease.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 180, doi. 10.1002/jcph.2148
- By:
- Publication type:
- Article
9
Comparison of Clinical Effectiveness Between Ambroxol and N-Acetylcysteine in Surgical Patients: A Retrospective Cohort Study.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 172, doi. 10.1002/jcph.2157
- By:
- Publication type:
- Article
10
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 166, doi. 10.1002/jcph.2149
- By:
- Publication type:
- Article
11
Drug Combination Modeling: Methods and Applications in Drug Development.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 151, doi. 10.1002/jcph.2128
- By:
- Publication type:
- Article
12
In Memoriam: Barry Dvorchik, BS, PhD, FCP.
- Published in:
- 2023
- By:
- Publication type:
- Obituary